FierceBiotech Dec 4, 2025 FDA names Tracy Beth Høeg, fresh from vaccine safety probe, as acting head of drug center
FierceBiotech Dec 4, 2025 FDA floats user fee cuts for early-stage US trials, additional fees for overseas development
FierceBiotech Dec 3, 2025 Capricor's phase 3 win sets up 2nd approval attempt for Duchenne cell therapy
FierceBiotech Dec 3, 2025 Fierce Biotech Fundraising Tracker '25: Triana glues $120M series B; Protego raises $130M
FierceBiotech Dec 3, 2025 With site 'irregularities,' Bristol Myers delays key Cobenfy readout in Alzheimer's psychosis
FierceBiotech Dec 3, 2025 Pfizer-backed Triana scores $120M series B to take molecular glue degrader into clinic
FierceBiotech Dec 2, 2025 Janux T-cell engager data sink stock, but analysts still see best-in-class potential
FierceBiotech Dec 2, 2025 Boston Scientific claims European approval for Farapoint focal pulsed field ablation catheter
FierceBiotech Dec 2, 2025 Imvax takes brain cancer cell therapy to FDA, betting survival hit will overshadow primary miss
FierceBiotech Dec 2, 2025 Tiziana to spin out IL-6 drug into new company, citing Big Pharma's interest in modality
FierceBiotech Dec 2, 2025 Roche's point-of-care whooping cough test greenlighted in US, Europe as cases surge